ASTROTECH Corp (ASTC) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-03-31..
Operating margin
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-03-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -13.81M USD | Operating Income (Loss) |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 6.98M USD | Research and Development Expense |
| Selling, general and administration | 7.17M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $-13.81M | (m) | (m) | $6.98M | $7.17M | (m) |
| 2025-12-31 | $-14.22M | (m) | (m) | $7.53M | $7.20M | (m) |
| 2025-09-30 | $-14.64M | (m) | (m) | $8.14M | $7.16M | (m) |
| 2025-06-30 | $-14.73M | $1.00M | (m) | $8.14M | $7.07M | -1473.40% |
| 2025-03-31 | $-15.16M | (m) | (m) | $8.01M | $7.58M | (m) |
| 2024-12-31 | $-14.83M | (m) | (m) | $7.73M | $7.30M | (m) |
| 2024-09-30 | $-13.57M | (m) | (m) | $6.87M | $7.28M | (m) |
| 2024-06-30 | $-13.28M | $1.70M | (m) | $6.79M | $7.24M | -781.18% |
| 2024-03-31 | $-12.67M | (m) | (m) | $6.90M | $6.67M | (m) |
| 2023-12-31 | $-11.88M | (m) | (m) | $6.55M | $6.24M | (m) |
| 2023-09-30 | $-11.63M | (m) | (m) | $6.33M | $5.78M | (m) |
| 2023-06-30 | $-11.06M | $750.00K | (m) | $5.59M | $5.78M | -1474.67% |
| 2023-03-31 | $-10.46M | (m) | (m) | $4.62M | $5.98M | (m) |
| 2022-12-31 | $-9.86M | (m) | (m) | $3.98M | $6.05M | (m) |
| 2022-09-30 | $-9.31M | (m) | (m) | $3.27M | $6.22M | (m) |
| 2022-06-30 | $-8.60M | $869.00K | (m) | $2.78M | $6.01M | -989.07% |
| 2022-03-31 | $-8.42M | (m) | (m) | $2.67M | $5.96M | (m) |
| 2021-12-31 | $-8.61M | $812.00K | (m) | $2.62M | $6.17M | -1060.59% |
| 2021-09-30 | $-7.91M | $387.00K | (m) | $2.72M | $5.24M | -2044.19% |
| 2021-06-30 | $-7.91M | $334.00K | (m) | $2.69M | $4.74M | -2368.26% |
| 2021-03-31 | $-7.97M | $488.00K | (m) | $2.87M | $4.62M | -1632.99% |
| 2020-12-31 | $-7.63M | $552.00K | (m) | $3.01M | $4.13M | -1382.07% |
| 2020-09-30 | $-8.11M | $621.00K | (m) | $3.19M | $4.44M | -1305.96% |
| 2020-06-30 | $-8.11M | $488.00K | (m) | $3.44M | $4.72M | -1662.70% |
| 2020-03-31 | $-7.85M | $411.00K | (m) | $3.16M | $4.71M | -1909.49% |
| 2019-12-31 | $-8.11M | $293.00K | (m) | $3.37M | $4.76M | -2768.60% |
| 2019-09-30 | $-8.25M | $95.00K | (m) | $3.33M | $4.93M | -8682.11% |
| 2019-06-30 | $-8.42M | $127.00K | (m) | $3.58M | $4.88M | -6627.56% |
| 2019-03-31 | $-10.90M | $85.00K | (m) | $4.37M | $4.90M | -12824.71% |
| 2018-12-31 | $-11.49M | $85.00K | (m) | $4.84M | $5.03M | -13523.53% |
| 2018-09-30 | $-12.49M | $119.00K | (m) | $5.50M | $5.37M | -10492.44% |
| 2018-06-30 | $-13.34M | $86.00K | (m) | $6.07M | $5.63M | -15508.14% |
| 2018-03-31 | $-11.96M | $432.00K | (m) | $6.20M | $6.09M | -2769.21% |
| 2017-12-31 | $-12.05M | $843.00K | (m) | $6.27M | $6.36M | -1429.30% |
| 2017-09-30 | $-11.57M | $1.32M | (m) | $5.96M | $6.37M | -875.26% |
| 2017-06-30 | $-12.06M | $2.33M | (m) | $5.59M | $7.51M | -518.04% |
| 2017-03-31 | $-12.85M | $3.48M | (m) | $6.08M | $7.69M | -368.67% |
| 2016-12-31 | $-13.84M | $3.27M | (m) | $6.42M | $7.93M | -423.24% |
| 2016-09-30 | $-13.85M | $3.68M | (m) | $6.50M | $7.97M | -376.75% |
| 2016-06-30 | $-13.84M | $2.67M | (m) | $6.47M | $7.71M | -518.08% |
| 2016-03-31 | $-18.37M | $1.30M | (m) | $5.39M | $13.14M | -1412.77% |
| 2015-12-31 | $-16.76M | $1.12M | (m) | $4.15M | $12.95M | -1501.61% |
| 2015-09-30 | $-17.05M | $193.00K | (m) | $3.81M | $13.29M | -8835.23% |
| 2015-06-30 | $-16.11M | $513.00K | (m) | $3.23M | $12.97M | -3140.55% |
| 2015-03-31 | $-6.94M | $16.63M | (m) | $3.04M | $9.54M | -41.71% |
| 2014-12-31 | $-6.64M | $16.66M | (m) | $3.02M | $9.29M | -39.82% |
| 2014-09-30 | $-5.93M | $10.05M | (m) | $2.39M | $9.30M | -59.01% |
| 2014-06-30 | $-5.68M | $16.42M | (m) | $2.50M | $8.89M | -34.59% |
| 2014-03-31 | $-2.59M | $19.96M | (m) | $2.39M | $6.99M | -12.98% |
| 2013-12-31 | $196.00K | $22.97M | (m) | $2.20M | $7.15M | 0.85% |
| 2013-09-30 | $2.02M | $24.56M | (m) | $2.24M | $6.43M | 8.23% |
| 2013-06-30 | $-559.00K | $24.00M | (m) | $2.08M | $6.79M | -2.33% |
| 2013-03-31 | $-3.19M | $22.42M | (m) | $2.09M | $6.96M | -14.21% |
| 2012-12-31 | $-2.03M | $27.87M | (m) | $2.10M | $7.01M | -7.28% |
| 2012-09-30 | $-3.04M | $27.43M | (m) | $2.46M | $7.24M | -11.07% |
| 2012-06-30 | $-2.29M | $26.14M | (m) | $2.57M | $7.07M | -8.76% |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $-5.75M | $20.15M | (m) | $3.83M | $8.40M | -28.56% |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |